HomeTagsAvenge Bio

Avenge Bio

Biotechnology

Avenge Bio Announces Peer-Reviewed Publication on Preclinical Proof-of-Concept

PR Newswire - August 24, 2022

Avenge Bio, Inc., a biotechnology company developing the LOCOcyte immunotherapy platform for the precision administration of potent immune effector molecules to treat solid tumors, ...

Biotechnology

Avenge Bio Announces Peer-Reviewed Publication on Preclinical Proof of Concept for LOCOcyte™ Platform Technology

PR Newswire - March 3, 2022

Avenge Bio, Inc., ("Avenge" or the "Company") a biotechnology company developing the LOCOcyte™ immunotherapy platform for the precision administration of potent immune effector molecules...